Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Invitrolize Logo
Invitrolize Growth Score
69
CB Rank
159816
Heat Score
61
Invitrolize provides innovative 3D alveolar in vitro model.
Founded
obfuscation
PrivateSeed Luxembourg, Luxembourg, Luxembourg1-10 invitrolize.com
3D Technology
Biotechnology
Overview

Invitrolize
Total Funding
obfuscation
Growth Score
69
Heat Score
61

Total Funding
obfuscation
Seed raised
obfuscation
Growth Score69
-7 pts
in past quarter
Heat Score 61
-5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Invitrolize

CB Rank
159816
Invitrolize provides innovative 3D alveolar in vitro model.
Founded
obfuscation
PrivateSeed Luxembourg, Luxembourg, Luxembourg1-10 invitrolize.com
3D Technology
Biotechnology

Funding Rounds

Seed
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Details

Operating Status Active
Company Type For Profit
About the Company
Invitrolize provides innovative 3D alveolar in vitro models that allow to prediction of the hazard of respiratory sensitization and irritation.
Predictions & Insights

Growth Insight

See this Growth Insight
Invitrolize is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

ALIsens®
A 3D human alveolar in vitro model that identifies and differentiates respiratory sensitizers and irritants under air-liquid interface exposure conditions.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Invitrolize Logo
Seed Round - Invitrolize
1
obfuscation
Expon CapitalSeed
obfuscation
Seed Round - Invitrolize Logo
Seed Round - Invitrolize
1
obfuscation
Expon CapitalSeed
obfuscation
Seed Round - Invitrolize Logo
Seed Round - Invitrolize
1
obfuscation
Expon CapitalSeed
obfuscation
Seed Round - Invitrolize Logo
Seed Round - Invitrolize
1
obfuscation
Expon CapitalSeed
obfuscation
Seed Round - Invitrolize Logo
Seed Round - Invitrolize
1
obfuscation
Expon CapitalSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Invitrolize Logo
Seed Round - Invitrolize
1
obfuscation
Expon CapitalSeed
obfuscation
Seed Round - Invitrolize Logo
Seed Round - Invitrolize
1
obfuscation
Expon CapitalSeed
obfuscation
Seed Round - Invitrolize Logo
Seed Round - Invitrolize
1
obfuscation
Expon CapitalSeed
obfuscation
Seed Round - Invitrolize Logo
Seed Round - Invitrolize
1
obfuscation
Expon CapitalSeed
obfuscation
Seed Round - Invitrolize Logo
Seed Round - Invitrolize
1
obfuscation
Expon CapitalSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News

News and Press

News•Oct 28, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 13, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 13, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

454
46.93%
 in past month

IT Spend

$308KThis year, Invitrolize is projected to spend $308K on IT, according to Aberdeen.

Active Website Tech Count

22Invitrolize is actively using 22 technologies for its website, according to BuiltWith. These include SSL by Default, HSTS, and  Google Tag Manager.

Total IP

1Invitrolize has 1 registered trademark in the 'Pharmaceutical, veterinary and sanitary products' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Invitrolize's headquarters? Invitrolize is located in Luxembourg, Luxembourg, Luxembourg.Who invested in Invitrolize? Invitrolize has 2 investors including Expon Capital and  Luxinnovation.When was the last funding round for Invitrolize? Invitrolize closed its last funding round on
obfuscation
from a Seed round.Who are Invitrolize's competitors? Alternatives and possible competitors to Invitrolize may include Emulate, Lonza, and  CN Bio.How much funding has Invitrolize raised to date? Invitrolize has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(6ec160d 1)
|